PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 25 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Bofutsushosan (containing S. divaricatum) improves body mass index (BMI) in participants with obesity [PMID:35417488].
Da-Fang-Feng-Tang (containing S. divaricatum) alleviated the severity of collagen-induced arthritis in mice, reducing anticollagen IgG antibodies and cartilage/bone erosion [PMID:10467454].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 35417488 (2022) — Japanese traditional Kampo medicine bofutsushosan improves body mass index in participants with obesity: A systematic review and meta-analysis. · PloS one
- 2.PMID: 17549372 (2007) — Anti-proliferative and antioxidant activities of Saposhnikovia divaricata. · Oncology reports
- 3.PMID: 37315642 (2023) — Jing-Fang n-butanol extract and its isolated JFNE-C inhibit ferroptosis and inflammation in LPS induced RAW264.7 macrophages via STAT3/p53/SLC7A11 signaling pathway. · Journal of ethnopharmacology
- 4.PMID: 10530783 (1999) — Inducible nitric oxide synthase inhibitor of the Chinese herb I. Saposhnikovia divaricata (Turcz.) Schischk. · Cancer letters
- 5.PMID: 28360931 (2017)